• A 59 year old man was referred to our endocrine service for persistently elevated prolactin levels in the range from 1477 to 1972 milliunit/L [60-300] for many years with negative macroprolactin.
• He did not report any headache, visual disturbance or galactorrhoea.
• He was diagnosed with schizophrenia in 1994 and was tried on different antiphychotic drugs until established on a combination of Amisulpride and Clozapine 11 years later.
• Further history revealed that he had been diagnosed with normocytic normochromic anaemia for which no cause had been identified.
• On direct questioning, the patient reported erectile dysfunction and loss of morning erections. He had not been sexually active since 1993.
• In addition, he had a history of un-provoked deep venous thrombosis and pulmonary embolism, hyperlipidaemia and diabetes mellitus type 2.
Examination:
• Physical examination showed a pale and tall man with central obesity and scanty body and facial hair.
• There was no gynaecomastia on breast examination.
• Testicular examination was not performed initially.
Introduction:
• Klinefelter syndrome (KS), 47,XXY, occurs in 150 per 100,000 live born males on neonatal karyotyping.
• British and Swedish studies estimate a prevalence of KS of 11.9 per 100,000 and 23.1 per 100,000 males respectively • It seems that only 25-40% of the pool of KS are ever diagnosed, and only about 10% of these are diagnosed during childhood and adolescent years, while the bulk of patients are diagnosed during adulthood, typically in the course of a fertility workup.
• There is no universal agreement on the necessary clinical signs or stigmata that should lead to karyotyping.
• The diagnosis of a male with KS rests on clinical appearance coupled with a karyotype of 47,XXY or mosaics form.
• The cardinal stigmata include small testes (which are present in virtually all KS), hypergonadotropic hypogonadism, gynecomastia, learning difficulties and infertility .
• Many other conditions can be associated with KS like diabetes mellitus , dyslipedemia, psychiatric disorder, mitral valve prolapse, breast cancer and extragonadal germ cell tumors.
Investigations:
• Blood results showed anemia with hormonal panel suggestive of primary hypogonadism (Table 1) . Hyperprolactinemia was felt to be secondary to antipsychotics and no pituitary MRI was carried out. Rest of the pituitary hormonal panel was within normal range.
• After confirmation with another set, karyotyping was requested and revealed 47,XXY consistent with Klinefelter syndrome.
• DEXA scan revealed osteopenia of the L2-L4 segment (T-score -1.2 ) and normal density of the femora (T-score 0.6 ).
Management:
• Patient was started on Transdermal testosterone replacement with significant improvement in haemoglobin level (Table 1) .
Discussion:
This case illustrates several points:
• Firstly, the diagnosis of Klinefelter syndrome may be missed due to very variable phenotypical presentations. Many conditions and different co-morbidities can be associated with KS (Table 2 ).
• Knowledge about the genotype-phenotype relation in KS is limited. Genetic mechanisms related to the X chromosome as well as the androgen receptor have been evaluated for a possible impact on the phenotype in KS. These genetic mechanisms include the parental origin of the supernumerary X chromosome, the pattern of X chromosome inactivation and the androgen receptor CAG repeat length (Figure 1 ).
• Secondly, testosterone deficiency can be a cause of unexplained anaemia (Table  3) .
• Thirdly, patients with Klinefelter syndrome can develop thromboembolic disease (4 to 8-fold) and are at risk of psychosis, autism and ADHD. 
Schizophrenia
A review of studies of male psychiatric inpatients from the 1960s to the 1990s found a frequency of KS ranging from 0 to 4.8% (mean, 0.8%) among schizophrenic patients, a 4-to 5-fold increase compared with the prevalence of KS in the general population. 
